New Delhi: Another vaccine has now been added to the country's ongoing vaccination against the corona epidemic. The 3 dose corona vaccine of pharma company Zydus Cadila has been approved by the Central Government. The name of this vaccine is ZyCov-D. An expert committee of the Drug Control General of India has allowed the vaccine to be used emergency on Friday. The committee has also sought additional data from the pharma company on the impact of 2 doses of the vaccine.

The generic pharmaceutical company Cadila Healthcare Limited had applied on July 1 last to allow emergency use of ZyCoV-D. The application was made on the basis of a final stage trial conducted on 28,000 volunteers. The vaccine's efficiency rate was 66.6 percent. It has also been reported that the vaccine is also completely safe for the age group of 12 to 18 years. However, its trial data has not been peer-reviewed so far.

The same would be India's second indigenous vaccine if the vaccine is fully approved after emergency use. Earlier, Bharat Biotech and ICMR had jointly made the first indigenous corona vaccine. At present, a total of 4 vaccines have been approved in the country. Covishield, Covaxin, Sputnik, Moderna. Now, the number will be 5 by adding the Zydus vaccine. Earlier, Zydus Cadila had said that she could introduce the vaccine within two months of receiving the approval.

Traffic police's deadly action, youth hanging in air with bike

Andhra Government extends COVID night curfew till September 4

Bengal violence: Another blow to Mamata govt, Kolkata High Court says big deal